| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
159,210,000 |
| Market
Cap: |
1.03(B) |
| Last
Volume: |
2,204,422 |
Avg
Vol: |
2,198,382 |
| 52
Week Range: |
$2.25 - $6.87 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drugs - Generic |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Amneal Pharmaceuticals is a holding company. Through its subsidiaries, Co. is a pharmaceutical company engaging in developing, manufacturing, marketing and distributing generic and branded pharmaceutical products across an array of dosage forms and therapeutic areas. Co. has three reportable segments: Generics, which includes various product families covering a range of dosage forms and delivery systems; Specialty, which is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products, with a focus on products addressing central nervous system disorders; and AvKARE, which provides pharmaceuticals, medical and surgical products, and services.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hsu Larry |
President and CEO |
• • – |
2009-11-20 |
4 |
D |
$11.34 |
$6,237 |
I/I |
(550) |
27,635 |
|
- |
|
| Sun Oh Kim |
Director |
– • – |
2009-11-12 |
4 |
OE |
$4.00 |
$8,000 |
D/D |
2,000 |
14,000 |
|
- |
|
| Markbreiter Michael |
Director |
– • – |
2009-11-06 |
4 |
S |
$9.70 |
$38,800 |
D/D |
(4,000) |
12,000 |
|
- |
|
| Markbreiter Michael |
Director |
– • – |
2009-11-06 |
4 |
OE |
$4.00 |
$19,250 |
D/D |
4,000 |
16,000 |
|
- |
|
| Hsu Larry |
President and CEO |
• • – |
2009-10-26 |
4 |
A |
$0.00 |
$0 |
I/I |
9,200 |
28,185 |
|
- |
|
| Hsu Larry |
President and CEO |
• • – |
2009-10-16 |
4 |
D |
$9.23 |
$6,599 |
I/I |
(715) |
18,985 |
|
- |
|
| Hsu Larry |
President and CEO |
• • – |
2009-10-07 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,000 |
2,354,568 |
|
- |
|
| Hsu Larry |
President and CEO |
• • – |
2009-09-28 |
4 |
GD |
$0.00 |
$0 |
I/I |
9,000 |
2,355,568 |
|
- |
|
| Hsu Larry |
President and CEO |
• • – |
2009-09-21 |
4 |
GD |
$0.00 |
$0 |
I/I |
6,000 |
2,364,568 |
|
- |
|
| Fleming Nigel |
Director |
– • – |
2009-08-14 |
4 |
S |
$7.69 |
$30,770 |
D/D |
(4,000) |
24,000 |
|
- |
|
| Fleming Nigel |
Director |
– • – |
2009-08-14 |
4 |
OE |
$4.00 |
$16,000 |
D/D |
4,000 |
28,000 |
|
- |
|
| Hsu Larry |
President and CEO |
• • – |
2009-08-13 |
4 |
GA |
$0.00 |
$0 |
D/D |
2,249 |
306,792 |
|
- |
|
| Hsu Larry |
President and CEO |
• • – |
2009-08-13 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,249 |
19,700 |
|
- |
|
| Nestor Michael |
President, Impax Pharm. Div. |
• – – |
2009-06-08 |
4 |
D |
$7.55 |
$20,242 |
D/D |
(2,681) |
42,894 |
|
- |
|
| Markbreiter Michael |
Director |
– • – |
2009-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
12,000 |
|
- |
|
| Sun Oh Kim |
Director |
– • – |
2009-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
12,000 |
|
- |
|
| Fleming Nigel |
Director |
– • – |
2009-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
24,000 |
|
- |
|
| Hildenbrand Charles V |
SVP, Operations |
• – – |
2009-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
27,000 |
32,000 |
|
- |
|
| Nestor Michael |
President, Impax Pharm. Div. |
• – – |
2009-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
13,000 |
45,575 |
|
- |
|
| Terreri Peter R |
Director |
– • – |
2009-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
12,000 |
|
- |
|
| Koch Arthur A Jr |
SVP, Finance, and CFO |
• – – |
2009-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
89,000 |
99,000 |
|
- |
|
| Hsu Larry |
President and CEO |
• • – |
2009-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
138,000 |
304,543 |
|
- |
|
| Burr Robert L |
Director |
– • – |
2009-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
41,150 |
|
- |
|
| Mengler Christopher |
President, Global Pharm. Div. |
• – – |
2009-05-08 |
4 |
B |
$5.85 |
$5,850 |
D/D |
1,000 |
47,000 |
2.74 |
- |
|
| Mengler Christopher |
President, Global Pharm. Div. |
• – – |
2009-03-25 |
4 |
B |
$5.50 |
$5,500 |
D/D |
1,000 |
46,000 |
2.74 |
- |
|
531 Records found
|
|
Page 18 of 22 |
|
|
0.01 (0.16%) 
